News - Pharmstandard


Current filters:


Popular Filters

Pharmstandard commits $30 million to Argos Therapeutics; post 1st-half results


Russia's largest drugmaker Pharmstandard (PHST: RU) that its subsidiary Pharmstandard International.(Luxembourg)…

AGS-003Argos TherapeuticsFinancialGenericsOncologyPharmaceuticalPharmstandardResearch

Pharmstandard agrees key terms for acquiring Singapore drugmaker


Russia's largest pharma company Pharmstandard (PHST RU) - with a market capitalization of around $2 billion…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmstandard

Pharmstandard confirms OTC spin-off and in talks to buy Bever Pharma


Russia's largest drugmaker Pharmstandard OJSC (PHST RU) has confirmed that it has initiated steps for…

Bever PharmaceuticalGenericsMergers & AcquisitionsPharmaceuticalPharmstandard

Pharmstandard may sell its non-Rx business for $2.5 billion; AbbVie Russian plans


Pharmstandard, Russia's largest drug producer, is considering selling its production of non-prescription…

AbbVieEuropeMergers & AcquisitionsPharmaceuticalPharmstandardProductionR-Pharma

Leading Russian vaccines producer Petrovax acquired by Pharmstandard


Russian drugmaker Pharmstandard is to acquire Petrovax Pharm, one of the country's largest producers…

Abbott LaboratoriesMergers & AcquisitionsPetrovax FarmPharmaceuticalPharmstandardVaccines

Italy's Chiesi eyes Russian expansion


Privately held Italian drugmaker Chiesi Farmaceutici is considering a massive expansion into the Russian…

Chiesi FarmaceuticiEuropeGenericsMarkets & MarketingPharmstandardProductionRespiratory and Pulmonary

AstraZeneca to invest $1.2 billion in Russia by 2017; Pharmstandard deal with AVVA


Anglo-Swedish drug major AstraZeneca (LSE: AZN) plans to invest up to $1.2 billion in its development…

AstraZenecaAVVA PharmaceuticalsEuropeFinancialMarkets & MarketingPharmaceuticalPharmstandardProduction

Back to top